Table 1. Comparison of clinical aspects in Giardia duodenalis positive and negative dogs affected by different type of chronic enteropathy.

Variable	G. duodenalis positive dogs (n. 16)	G. duodenalis negative dogs (n. 31)	p-values
CCECAI	MI+CI 11/16 (68.8%) S+M 5/16 (31.3%)	MI+CI 11/31 (35.5%) S+M 20/31 (64.5%)	p = 0.037**
FSI	N 3/16 (18.8%) SA 6/16 (37.8%) SVA 7/16 (43.8%)	N 2/31 (6.5%) SA 5/31 (16.1%) SVA 24/31 (77.4%)	p = 0.068*
MU and/or B	MU 4/16 (25%) B 3/16 (18.8%)	MU 12/31 (38.7%) B 10/31 (32.3%)	p (MU) = 0.517** p (B) = 0.494**
FD	N 9/16 (56.3%) I 7/16 (43.8%)	N 7/31 (22.6%) I 24/31 (77.4%)	p = 0.056**
Type of enteropathy	FRE 5/16 (31.3%) ARE 9/16 (56.3%) IRE 2/16 (12.5%) PLE 2/16 (12.5%)	FRE 13/31 (41.9%) ARE 13/31 (41.9%) IRE 5/31 (16.1%) PLE 9/31 (29%)	p = 0.647*

ARE, antibiotic-responsive enteropathy; B, presence of blood in feces; CCECAI, Canine Chronic Enteropathy Activity Index; CI, clinically insignificant; FD, frequency of defecation; FRE, food-responsive enteropathy; FSI, fecal score index; I, increased; IRE, immunosuppressant-responsive enteropathy; M, moderate; MI, mild; MU, presence of mucus; N, normal (FSI 2-4/7); PLE, protein losing enteropathy; S, severe; SA, slightly altered (FSI 5/7); SVA, severely altered (FSI 6-7/7).

^(*):Chi-square test

^(**):Fisher’s exact test.